Temozolomide ≥98%|CAS:85622-93-1|25 mg|100 mg|500 mg

Methazolastone; Temodal; Temodar|Temozolomide is a second generation imidazotetrazine anticancer chemotherapeutic that is clinically approved to treat gliobastoma multiforme, anaplastic astrocytoma, and oligodendrocytoma. Temozolomide acts as an alkylating agent, attaching alkyl groups to guanine bases in DNA and interfering with DNA replication. This compound is 100% orally bioavailable and enters the cerebrospinal fluid easily and quickly.|C6H6N6O2|194.15||+4°C|Soluble in DMSO to 39mg/mL, Water to 5 mg/mL, Ethanol <1mg/mL